Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality-Reference-Cited by-同舟云学术

Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality

Published:2022-04 Issue:4 Volume:161 Page:1101-1111
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Huang Junjie,Deng Yunyang,Tin Man Sing,Lok Veeleah,Ngai Chun Ho,Zhang Lin,Lucero-Prisno Don Eliseo,Xu Wanghong,Zheng Zhi-Jie,Elcarte Edmar,Withers Mellissa,Wong Martin C.S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference26 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control;Jemal;J Natl Cancer Inst,2008

3. The effect of advances in lung-cancer treatment on population mortality;Howlader;N Engl J Med,2020

4. Lung cancer mortality in Australia: projected outcomes to 2040;Luo;Lung Cancer,2018

5. Exposure to secondhand smoke and risk of cancer in never smokers: a meta-analysis of epidemiologic studies;Kim;Int J Environ Res Public Health,2018

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and multi-model prediction of hepatitis B incidence in Xiamen;Infectious Disease Modelling;2024-12

2. Towards automatic forecasting of lung nodule diameter with tabular data and CT imaging;Biomedical Signal Processing and Control;2024-10

3. New findings on the incidence and management of CNS adverse reactions in ALK-positive NSCLC with lorlatinib treatment;Discover Oncology;2024-09-13

4. A scoring model for the expression of genes related to programmed cell death predicts immunotherapy response and prognosis in lung adenocarcinoma;Discover Oncology;2024-09-12

5. IL-22: A key inflammatory mediator as a biomarker and potential therapeutic target for lung cancer;Heliyon;2024-09